UnitedHealth Group, a leading health care and well-being company, reported a robust financial performance for the year ended December 31, 2023. The company saw a 15% increase in consolidated revenues, reaching $371.622 billion, driven by growth in Medicare Advantage and Medicaid, as well as across its Optum businesses. UnitedHealthcare's revenues rose by 13%, while Optum's revenues grew by 24%. The company's earnings from operations also increased by 14%, with UnitedHealthcare and Optum contributing equally to this growth. Diluted earnings per share for UnitedHealth Group shareholders increased by 13% to $23.86. The company's medical care ratio (MCR) increased slightly to 83.2%, reflecting elevated care activity, particularly outpatient care for seniors. UnitedHealth Group's operating cost ratio remained consistent at 14.7%, and the return on equity was a...Show More

UnitedHealth Group, a leading health care and well-being company, reported a robust financial performance for the year ended December 31, 2023. The company saw a 15% increase in consolidated revenues, reaching $371.622 billion, driven by growth in Medicare Advantage and Medicaid, as well as across its Optum businesses. UnitedHealthcare's revenues rose by 13%, while Optum's revenues grew by 24%. The company's earnings from operations also increased by 14%, with UnitedHealthcare and Optum contributing equally to this growth. Diluted earnings per share for UnitedHealth Group shareholders increased by 13% to $23.86. The company's medical care ratio (MCR) increased slightly to 83.2%, reflecting elevated care activity, particularly outpatient care for seniors. UnitedHealth Group's operating cost ratio remained consistent at 14.7%, and the return on equity was a strong 27.0%. In terms of business development, UnitedHealth Group continues to focus on improving access, affordability, outcomes, and experiences in health care through its two complementary businesses, Optum and UnitedHealthcare. The company operates in the United States and international health markets, expecting health care spending to grow due to various factors, including inflation and medical technology advancements. UnitedHealth Group's future plans include accelerating the transition from fee-for-service to value-based care, which requires investments in system enhancements and clinical engagement. The company also completed the sale of its operations in Brazil, recording a loss of approximately $7 billion in the first quarter of 2024, primarily due to foreign currency translation losses.